<DOC>
	<DOCNO>NCT00552773</DOCNO>
	<brief_summary>To evaluate efficacy safety Cyclamen europaeum extract 10 % ( v/v ) compare placebo subject acute sinusitis</brief_summary>
	<brief_title>Pilot Study Determine Efficacy Cyclamen Europaeum Extract Nasal Spray Patients With Acute Sinusitis</brief_title>
	<detailed_description />
	<mesh_term>Sinusitis</mesh_term>
	<mesh_term>Acute Disease</mesh_term>
	<criteria>1 . Adults age 1870 2 . Must symptomatic basis subject assessment total sympton score . 3 . Evidence mucopurulence nasal endoscopy 4 . Evidence inflammation upon nasal endoscopy 5 . CT scan radiographic sign acute sinusitis 6 . Able complete study activity procedures end study , include visit test , capable selfadministration study medication 7 . Agree abide study protocol restriction 1 . Known history hypogammaglobulinemia , immotile cilium syndrome , atrophic rhinitis , rhinitis medicamentosa , cystic fibrosis 2 . Known hypersensitivity Cyclamen , Primula , Primulaceae 3 . Serious unstable comorbidity malignancy ( squamous basal cell carcinoma skin ) sever renal hepatic disease . 4 . Abnormal screen laboratory/imaging test result 5 . Condition ( ) compromise ability either administer agent ass risks/benefits ( eg mucocele , choanal polyp , Stage 4 polyposis cyst extend inferior turbinate , deviate septum , facial trauma , birth defect ) 6 . Expansile mass bony erosion sinus radiograph 7 . Females pregnant , plan become pregnant currently breastfeed . 8 . History viral upper respiratory infection ( URI ) past 2 week 9 . Temperature great 102.5Â°F 10 . Facial periorbital edema 11 . Local complication include orbital cellulitis ; acute abnormality extraocular movement ; cavernous vein thrombosis ; dental facial abscess 12 . Altered mental status 13 . Recent nasal sinus surgery ( within 3 month less ) plan surgery within next 3 month 14 . Use intranasal antibiotic within previous 30 day systemic antibiotic within previous 15 day 15 . Use oral and/or topical nasal decongestant within previous 7 day 16 . Had radiation therapy chemotherapy within previous 12 month 17 . Have use investigational drug device within 30 day prior screen 18 . Have history illegal drug alcohol abuse within past 5 year 19 . Have major unstable organ system disease could place subject increase risk complication , interfere study participation , confound study objective Subjects asthma , seasonal and/or perennial allergic rhinitis allow enter study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>SINUSITIS</keyword>
	<keyword>CYCLAMEN</keyword>
</DOC>